Altogether, we provided the evidence for the first time that the SNHG1 expression is predominantly augmented in colorectal cancer compared to paired-adjacent non-tumorous tissues, and demonstrated that SNHG1 may play a key oncogenic role as a predictor of poor survival and a negative prognostic factor for patients with colorectal cancer. The gene discussed is SNHG1; the disease is colorectal cancer.